CHA2DS2-VASc score predicts contrast induced nephropathy in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention
Event:
ESC Congress 2018
Topic:
Revascularisation
Session:
Coronary artery disease: diagnosis, pharmacotherapy and revascularisation